Skip to content
EUSA Pharma logo

EUSA Pharma Alternatives & Competitors

12 companies similar to EUSA Pharma — Part of Recordati Rare Diseases, the business unit dedicated to rare diseases in...

Companies similar to EUSA Pharma

Biodexa Pharmaceuticals PLC logo — alternative to EUSA Pharma

Biodexa Pharmaceuticals PLC

Advancing Medicines for a Brighter Future

Biogen logo — alternative to EUSA Pharma

Biogen

Innovative therapies worldwide for people living with serious neurological and neurodegene...

Centurion İlaç logo — alternative to EUSA Pharma

Centurion İlaç

Her hasta modern tedavi şansını ve yüksek yaşam kalitesini hak eder…

VEM PHARMACEUTICALS logo — alternative to EUSA Pharma

VEM PHARMACEUTICALS

For a Healthier Future

Rival Readout

Competing with EUSA Pharma? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
KAMADA logo — alternative to EUSA Pharma

KAMADA

Specialty Plasma-Derived Therapeutics

Juvisé Pharmaceuticals logo — alternative to EUSA Pharma

Juvisé Pharmaceuticals

What we provide is essential

Takeda logo — alternative to EUSA Pharma

Takeda

Better Health, Brighter Future

Ipsen logo — alternative to EUSA Pharma

Ipsen

Engineers and develops bacterial-based protein therapeutics for the treatment of neurologi...

Paladin Labs logo — alternative to EUSA Pharma
Roivant logo — alternative to EUSA Pharma

Roivant

Reinventing Biopharma

Redx Pharma logo — alternative to EUSA Pharma

Redx Pharma

Biotech company focusing on the discovery and development of novel targeted medicines to t...

Provepharm logo — alternative to EUSA Pharma

Provepharm

Act to improve life

About EUSA Pharma

EUSA Pharma, a subsidiary of Recordati Rare Diseases, stands at the forefront of addressing critical gaps in adult and pediatric care for cancer and rare disease patients globally. Founded in 2006, this United Kingdom-based company operates within the Biotechnology, Health Care, and Pharmaceutical sectors. As part of t...

Services

Development of Medicines, Commercialization of Medicines, Healthcare Research, Pharmaceutical Manufacturing

Target Customers

Patients with Common Diseases, Patients with Rare Diseases, Investors, Healthcare Professionals

Business keywords

Rare Diseases, Cancer Treatment, Specialty Pharmaceuticals, Adult And Pediatric Care, Pharmaceutical Development, Pharmaceutical Manufacturing, Pharmaceutical Marketing, Acquisition And In-licensing, Life Science Investments, Global Distribution Network, Oncology Products, Oncology Supportive Care, Hospital Products, Product Expansion

Business Model

B2B

Revenue Model

Product Sales, Licensing, Service Fee

Frequently Asked Questions

Companies similar to EUSA Pharma include Biodexa Pharmaceuticals PLC, Biogen, Centurion İlaç, VEM PHARMACEUTICALS, KAMADA. They work in Biotechnology and Pharmaceutical and share EUSA Pharma's focus on specialty pharmaceuticals, pharmaceutical manufacturing and rare diseases.
Bounce Watch lists 12 companies that share EUSA Pharma's industries and are closest to it in business tags, services, target customers, business model and size.
EUSA Pharma, a subsidiary of Recordati Rare Diseases, stands at the forefront of addressing critical gaps in adult and pediatric care for cancer and rare disease patients globally. Founded in 2006, this United Kingdom-based company operates within the Biotechnology, Health Care, and Pharmaceutical sectors. As part of t...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around EUSA Pharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at EUSA Pharma on 11 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout